Bg Medicine Inc (BGMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2008 | |
| Cash Flows From Operating Activities | |
| Net Income | -15,070 |
| Depreciation Amortization | 590 |
| Other Working Capital | -1,090 |
| Other Operating Activity | 5,970 |
| Operating Cash Flow | $-9,600 |
| Cash Flows From Investing Activities | |
| PPE Investments | -380 |
| Other Investing Activity | -7,150 |
| Investing Cash Flow | $-7,530 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 35,970 |
| Financing Cash Flow | $35,970 |
| Beginning Cash Position | 1,210 |
| End Cash Position | 20,050 |
| Net Cash Flow | $18,830 |
| Free Cash Flow | |
| Operating Cash Flow | -9,600 |
| Free Cash Flow | -9,600 |